ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

Fondazione IRCCS Istituto Nazionale dei Tumori at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Fondazione IRCCS Istituto Nazionale dei Tumori takes part in 33 sessions at ESMO 2026 in Madrid. Its program spans lung, gastrointestinal and genitourinary cancers, alongside the use of artificial intelligence in cancer care. It examines how artificial intelligence can help match people with lung cancer to clinical trials.

OrganizationESMO 2026 Attendance
Cancer centre & hospital
Public cancer hospital and scientific research institute in Milan, Italy.
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
13:00–15:00
Chair
Fri Oct 23
13:30–15:00
Proffered paper 1: Gastrointestinal tumour, upper digestive
with Oxford University Hospitals NHS Foundation Trust
Gastrointestinal cancers
Abstract
Fri Oct 23
14:00–14:12
Invited Discussant LBA77, LBA78 and 2875O
Proffered paper 1: Gastrointestinal tumour, upper digestive
Gastrointestinal cancers
Poster
Fri Oct 23
15:15–16:00
Poster
Fri Oct 23
15:15–16:00
Early-on-treatment neutrophil dynamics predict first-line therapy outcome in advanced NSCLC: An explainable machine learning survival analysis
Friday Poster Display session 1
Lung & thoracic cancersBiomarkers & precision oncology
Poster
Fri Oct 23
15:15–16:00
Feasibility of spatial transcriptomic profiling for assessing chemotherapy-induced tumor and microenvironment changes in head and neck, colorectal, and triple-negative breast cancers: A proof-of-concept study
Friday Poster Display session 3
Gastrointestinal cancersBreast cancerSarcoma, CNS, head & neck and rare cancersBiomarkers & precision oncology
Poster
Fri Oct 23
15:15–16:00
Chair
Sat Oct 24
10:15–11:45
Chair
Sat Oct 24
10:15–11:00
Integrating experiences in treating oligometastatic HNC patients
Sarcoma, CNS, head & neck and rare cancers
Talk
Sat Oct 24
10:55–11:15
Treat or wait? Therapeutic decisions in oligometastatic disease and borderline situations
Beyond guidelines: Expert navigation through the grey zones of oncology practice
Talk
Sat Oct 24
11:00–11:20
Radio-oncology perspective
Borderline resectable, non-oncogene driven stage III NSCLC
Lung & thoracic cancers
Talk
Sat Oct 24
15:35–15:50
View of the surgeon
Management of locally advanced HCC
Gastrointestinal cancers
Abstract
Sat Oct 24
15:50–16:02
Invited Discussant 3714O and 3716O
Proffered paper: Sarcoma
Sarcoma, CNS, head & neck and rare cancers
Talk
Sat Oct 24
16:35–16:55
Minimum requirements in the pathology reports
A multidisciplinary approach to Mixed Neuroendocrine-Non- neuroendocrine Neoplasms (MiNEN)
Sarcoma, CNS, head & neck and rare cancers
Chair
Sat Oct 24
18:30–20:00
Talk
Sat Oct 24
18:45–19:00
State of the art systemic therapy for patients with HER2+ metastatic gastroesophageal adenocarcinoma: When more is better?
ESMO Colloquium supported by Jazz Pharmaceuticals - Optimising the management of patients with advanced HER2+ gastroesophageal adenocarcinoma: ‘Testing’ the way to efficacy and safety
Gastrointestinal cancersBiomarkers & precision oncology
Poster
Sun Oct 25
12:00–12:45
A human-in-the-loop approach for clinical trial matching in lung cancer
Sunday Poster Display session 1
Lung & thoracic cancers
Poster
Sun Oct 25
12:00–12:45
A prospective silent trial of a neuro-symbolic AI platform for safe and usable clinical trial matching
Sunday Poster Display session 1
Lung & thoracic cancersGenitourinary cancers
Poster
Sun Oct 25
12:00–12:45
LLM-on-hub: A platform for structuring real-world EHRs data across a pan-cancer cohort
Sunday Poster Display session 1
Lung & thoracic cancersBreast cancerMelanoma & skin cancersGenitourinary cancers
Poster
Sun Oct 25
12:00–12:45
Poster
Sun Oct 25
12:00–12:45
Poster
Sun Oct 25
12:00–12:45
PD-L1 expression and tumor infiltrating lymphocytes (TILs) refine the prognostic stratification over immunoscore (IS) in resected pMMR colon cancer (CC)
Sunday Poster Display session 5
Gastrointestinal cancersBiomarkers & precision oncology
Chair
Sun Oct 25
14:45–16:15
Coming soon to your clinic? New therapies and approaches for lung cancer
with Lausanne University Hospital (CHUV)
Lung & thoracic cancers
Chair
Sun Oct 25
14:45–16:15
State-of-the-art treatment for non metastatic upper GI cancers
with Memorial Sloan Kettering Cancer Center
Gastrointestinal cancers
Talk
Sun Oct 25
15:45–16:05
Artificial intelligence & lung cancer: How AI can help us make better decisions in lung cancer care
Coming soon to your clinic? New therapies and approaches for lung cancer
Lung & thoracic cancers
Talk
Sun Oct 25
17:15–17:30
Can we personalise and de-escalate treatment strategies?
Peri-operative management of urothelial cancer
Genitourinary cancers
Poster
Mon Oct 26
12:00–12:45
Bridging endemic and non-endemic (NE) EBV-related nasopharyngeal carcinoma (NPC): Applying 9th TNM and phenotypic classification in NE NPC
Monday Poster Display session 2
Sarcoma, CNS, head & neck and rare cancers
Poster
Mon Oct 26
12:00–12:45
Risk stratification in surgically treated thoracic malignant peripheral nerve sheath tumors: A multicenter analysis
Monday Poster Display session 6
Sarcoma, CNS, head & neck and rare cancersLung & thoracic cancers
Poster
Mon Oct 26
12:00–12:45
Temporal trends in presentation, management and outcomes of surgically treated thymic epithelial tumors: Evidence from the Italian TYME Network
Monday Poster Display session 5
Lung & thoracic cancersSarcoma, CNS, head & neck and rare cancers
Talk
Mon Oct 26
12:15–12:30
How should oncologists prompt generative AI?
What oncologists should know about generative AI to support their clinical practice
Chair
Mon Oct 26
14:45–16:15
Rapid oral 2: Gastrointestinal tumour, upper digestive
with University of Glasgow, Hannover Medical School
Gastrointestinal cancers
Abstract
Mon Oct 26
14:55–15:07
Invited Discussant LBA84, LBA85 and 3137RO
Rapid oral 2: Gastrointestinal tumour, upper digestive
Gastrointestinal cancers

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Fondazione IRCCS Istituto Nazionale dei Tumori

Tell us what you sell and we’ll find the people at Fondazione IRCCS Istituto Nazionale dei Tumori most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction